AKEBIA THERAPEUTICS, INC. Accrued Bonuses, Current
AKEBIA THERAPEUTICS, INC. (AKBA) had Accrued Bonuses, Current of $7.74 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2019-11-12
- 2019-09-30: Accrued Bonuses, Current $7.74M.
- 2019-06-30: Accrued Bonuses, Current $5.63M.
- 2019-03-31: Accrued Bonuses, Current $4.21M.
- 2018-12-31: Accrued Bonuses, Current $9.54M.
| Period end | Accrued Bonuses, Current | Accrued Bonuses, Current as first filed |
|---|---|---|
| 2019-09-30 | $7.74M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.63M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.21M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.54M 10-Q · filed 2019-11-12 | |
| 2018-09-30 | $3.48M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.31M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $3.39M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $2.40M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.75M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $825.00K 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.00M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $1.88M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.25M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $679.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.18M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $1.24M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $653.00K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $328.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $1.29M 10-K · filed 2016-03-14 | $1.29M 10-K · filed 2015-03-04 |
| 2014-09-30 | $626.34K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $378.63K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $135.80K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $439.44K 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |